High-grade gliomas are rare, malignant tumours which account for up to 12% of all childhood brain tumours

The partnership will provide six MRC clinical fellows with industry placement opportunities

Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually

The nanocage technology combines both mRNA and traditional virus-based vaccines to create virus-like efficacious vaccines

The funding aims to reduce health inequalities in these groups and save more lives

The network will support the development, evaluation and adoption of innovative health and care technology